If you haven't seen me around much lately, it's because I've been very busy working on the EGFR Resisters project, plus I've enrolled in a clinical trial. I want to NYC last week for my initial consultation with Dr. Helena Yu at Memorial Sloan Kettering, and signed the informed consent form. Now comes 6 crazy weeks, full of doctor appointments, tests, plus a planned trip to Ohio to visit my brother and go to the cancergrace.org Targeted Therapies in Lung Cancer Patient Forum. My husband and I are back in NYC tomorrow so I can have a full battery of tests on Friday - MRI of brain, CT scans, echocardiogram, EKG, blood work, and eye examination. A link to the study is at the end of this post. It is combining Tarceva (erlotinib) and Mekinist (trametinib), a MEK inhibitor, and could be a good choice for my current unusual mutation status of having both EGFR and BRAF.
I am incredibly impressed with Dr. Yu and with MSKCC. So far every contact has been pleasant, and staff across all levels of the operation have been friendly and responsive.
I'll report back as I can, and plan to write a blog post about the conference in Ohio. It's being held at the Cleveland Clinic, so I'll get a peek at another excellent cancer center.